Wockhardt surges 3% on USFDA nod to market pain-relieving drug
Shares of drug firm Wockhardt rose by nearly 3 percent on Monday as the company received approval from the US health regulator to market its Oxycodone HCl liquid, used for treating chronic pain, in the American market.
Jun 22, 2015, 19:34 PM IST
Wockhardt recalls 93K bottles of Captopril tablets from US
Recall has been initiated as the tablets failed to meet tablet/capsule specifications given by the USFDA.
May 14, 2015, 17:40 PM IST
Wockhardt shares slump over 6% on recall of some drugs
After falling 11.2 percent to Rs 1,181 in intra-day trade on the BSE, shares of the company finally ended at Rs 1,243.35, down 6.52 percent.
Apr 28, 2015, 18:16 PM IST
Wockhardt says FDA raises new concerns about Waluj plant
Shares in Wockhardt Ltd fell as much as 5.3 percent on Thursday after the drugmaker said the U.S. Food and Drug Administration had raised fresh concerns about a plant already banned from exporting to the United States over quality issues.
Feb 26, 2015, 16:41 PM IST
